Artelo Biosciences (ARTL) Shares Outstanding (Diluted) (2017 - 2025)
Artelo Biosciences' Shares Outstanding (Diluted) was 38,111 in Q4 2025, up 91.6% from 19,895 a year earlier and up 30.7% from the prior quarter.
Analysis
Artelo Biosciences (ARTL) Shares Outstanding (Diluted) (2017 - 2025) Analysis & Trends
From Q4 2017 onward, Artelo Biosciences has reported Shares Outstanding (Diluted) for 33 quarters.
- Shares Outstanding (Diluted) shows a five-year compound annual growth rate of 93.4% (FY2020 to FY2025).
- In earlier years, Shares Outstanding (Diluted) was 19,895 in FY2024 (+8.9%), 18,272 in FY2023, 1,410 in FY2022 (unchanged) and 1,410 in FY2021.
- The Q4 2025 figure marks the highest quarterly Shares Outstanding (Diluted) in data going back to Q4 2017.
- Compared with a year earlier, Shares Outstanding (Diluted) has increased for six straight quarters, with growth averaging 27.6% over the last six quarters.
- The year-over-year growth in Shares Outstanding (Diluted) has ranged between 0.0% (Q2 2021) and 91.6% (Q4 2025) over the last five years.
- Per Business Quant data, ARTL's Shares Outstanding (Diluted) in the three quarters before Q4 2025 was 29,148 (Q3 2025), 21,259 (Q2 2025) and 20,253 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Artelo Biosciences | 76,308.92 | -5.06 Mn | - | 38,111.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 38,111.00 |
| Sep 30, 2025 | 29,148.00 |
| Jun 30, 2025 | 21,259.00 |
| Mar 31, 2025 | 20,253.00 |
| Dec 31, 2024 | 19,895.00 |
| Sep 30, 2024 | 19,926.00 |
| Jun 30, 2024 | 19,926.00 |
| Mar 31, 2024 | 19,735.00 |
| Dec 31, 2023 | 18,272.00 |
| Sep 30, 2023 | 18,204.00 |
| Jun 30, 2023 | 1,410.00 |
| Mar 31, 2023 | 1,410.00 |
| Dec 31, 2022 | 1,410.00 |
| Sep 30, 2022 | 1,410.00 |
| Jun 30, 2022 | 1,410.00 |
| Mar 31, 2022 | 1,410.00 |
| Nov 30, 2021 | 1,410.00 |
| Aug 31, 2021 | 1,410.00 |
| May 31, 2021 | 1,410.00 |
| Feb 28, 2021 | 1,410.00 |
API Access
Artelo Biosciences Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ARTL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "ARTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ARTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();